|
|
Other links at Articles > Business of Medicine |
| 2. |
FDA Finds No Link Between Statin Use and ALS
|
|
|
The meta-analysis, which included 41 clinical trials, revealed similar rates of ALS in the statin-treated and placebo-treated patients. The agency said further monitoring is still needed, however, because of the expansive use of the drugs and the dire consequences of this neurodegenerative disorder. Medscape Medical News
|
| 3. |
Heart-Imaging Agent Gets FDA Approval
|
|
|
Drug makers CV Therapeutics and Astellas Pharma Inc said on Friday the U.S. Food and Drug Administration (FDA) had approved their heart-imaging agent regadenoson, also called Lexiscan. Reuters Health Information
|
|
|
